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Background: There is often substantial mismatch between the diameters of the
pulmonary and aortic anuli in young patients with systemic outflow tract
disease. To implant the autologous pulmonary valve in the aortic position
under such circumstances, it is necessary to adapt the geometry of the systemic
outflow tract. The effects of such adaptations on autograft function in children
are not well known. Methods: To determine factors predictive of autograft
regurgitation, we analyzed 41 cases of children who have undergone the Ross
procedure. The diameter of the pulmonary valve was greater (by at least 3 mm)
than that of the aortic valve in 20 cases, equal (within 2 mm) in 12 cases, and
less (by at least 3 mm) in nine cases, with differences ranging from 110 to –12
mm. In 12 patients with a larger pulmonary anulus, aortoventriculoplasty was
used to correct the mismatch. In patients with a larger aortic anulus, the
mismatch was corrected by gradual adjustment along the circumference of the
autograft, rather than by tailoring of the native aortic anulus. Results: At
follow-up (median 31 months), two patients had undergone reoperation on the
neoaortic valve for moderate regurgitation. In the remaining 38 cases, au-
tograft regurgitation was as follows: none or trivial in 30, mild in seven, and
moderate in one. There was no correlation between regurgitation and age,
geometric mismatch, or previous or concurrent procedures. Conclusions: Subtle
technical factors that may result in distortion of the valve complex are
probably more important determinants of autograft regurgitation than are
indication for repair, geometric mismatch, or previous or concomitant outflow
tract procedures. Significant mismatch of the semilunar anuli is not a
contraindication to the Ross procedure in children. (J Thorac Cardiovasc Surg
1998;115:1255-63)
At many centers, the Ross procedure has becomethe preferred option for aortic valve replacement
in children.1-8 The pulmonary autograft has demon-
strated long-term functional integrity in the aortic
position,9, 10 and the promise of growth potential
appears to be realized.3, 7, 11 As the merits of this
procedure become established, it is being applied in
increasingly diverse situations.4, 5, 11-15 In many chil-
dren undergoing the Ross procedure for congenital
heart lesions, there is a significant discrepancy be-
tween the pulmonary and aortic anuli, with differ-
ences in diameter as large as 10 mm or more in
either direction. There has been no systematic study
examining whether such mismatch constitutes a
contraindication to the Ross procedure in children.
To optimize autograft valve function, any degree of
geometric mismatch requires focused surgical atten-
tion. Several techniques have been described for
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implanting the pulmonary autograft in place of a
larger15-17 or smaller13, 14 aortic valve. In this study
we reviewed our experience with the Ross proce-
dure in children, with a focus on the surgical man-
agement of geometric mismatch of the pulmonary
and aortic anuli and on the effects on autograft valve
function of such mismatch and of other surgical and
morphologic variables.
Patients and methods
Patients. Between July 1992 and December 1996, 41
children between the ages of 7 days and 18 years (median
7.8 years) underwent aortic valve replacement with the
pulmonary autograft at the University of California, San
Francisco Medical Center. The distribution of ages is
depicted in Fig. 1. This does not include four neonates
with borderline hypoplastic left heart syndrome in whom
a Ross procedure was part of a more complex operation
performed in an attempt to save the patient after the
parents refused a Norwood operation and heart trans-
plantation. Indications for the Ross procedure are sum-
marized in Table I. In 15 of the 41 children the Ross
operation was performed as the first surgical procedure; in
seven it was the first aortic valve intervention of any kind.
Previous left ventricular outflow tract interventions are
summarized in Table II.
Preoperative imaging studies. Preoperative cross-sec-
tional echocardiography was performed at our institution
for all patients. The aortic and pulmonary anuli were
measured at the hinge point of the valves in views
obtained from the parasternal long axis window, subcostal
window, or both. Off-line measurements were made ret-
rospectively by an echocardiographer who was unaware of
operative details and the results of follow-up. Each mea-
surement was made twice, and the average of the two
values was recorded for analysis.
No patient was found to have abnormal pulmonary
valve morphologic characteristics. The diameter of the
pulmonary valve was greater (by at least 3 mm) than that
of the aortic valve in 20 cases, equal (within 2 mm) in 12
cases, and less (by at least 3 mm) in nine cases, with
differences ranging from 110 to –12 mm. A ratio of
annular mismatch (the difference between pulmonary and
aortic annular diameters) to pulmonary annular diameter
([pulmonary anulus 2 aortic anulus]/pulmonary anulus)
was calculated from the absolute values. This ratio ranged
from –0.7 to 10.6.
Preoperative catheterization (within 2 years) was per-
formed in 25 patients. Eight of these underwent balloon
aortic valvuloplasty at that time.
Surgical techniques. Complete root replacement was
the technique of pulmonary autograft implantation in all
cases. In general the technique we employ is similar to
those previously described by others.1-3 This procedure
was performed in 15 of the 41 patients in this study. Large
coronary buttons, comprising essentially the entire wall of
the coronary sinuses, were mobilized for reimplantation
into the autograft so that the autograft sinuses were
essentially completely replaced by native aortic wall tissue.
The noncoronary aortic sinus was left in situ as a proxi-
mally based flap and incorporated into the autograft–to–
ascending aorta anastomosis, serving to buttress the non-
coronary sinus of the autograft externally.
In only 12 of the 41 patients were the aortic and
pulmonary valve diameters within 2 mm in size. Size
disparities ranged from a pulmonary valve 10 mm larger
than the aortic valve to an aortic valve 12 mm in excess of
the pulmonary valve. In the 12 patients in whom the
diameters of the aortic and pulmonary anuli were within 2
mm (group I), no specific adaptations were necessary to
implant the autograft into the aortic position, and the
Ross procedure was performed with a running suture
technique of autograft implantation. In cases of geometric
mismatch of at least 3 mm, however, technical adaptations
were necessary to ensure proper autograft fit and func-
tion.
In 12 of the 20 cases in which the pulmonary valve was
larger than the aortic valve, a Ross-Konno technique was
employed (group II).14 This operation, which we de-
scribed elsewhere,14 consists of implanting the autograft
pulmonary valve into the left ventricular outflow tract
after the aortic anulus and interventricular septum have
been incised in the manner used for a Konno procedure
(Fig. 2). The septal defect thus created is incorporated
into the autograft suture line, and the defect is patched
with either an extension of infundibular muscle harvested
with the autograft or a patch of synthetic material. Oth-
erwise, the technique is the same as that employed for a
standard Ross procedure.
When the native aortic anulus was larger than the
pulmonary autograft by at least 3 mm (n 5 9), we excised
the autograft with a slightly larger than usual cuff of
infundibular muscle (Fig. 3). The cuff of muscle attached
to the autograft was used to compensate for differences in
annular size. With a running suture technique, the larger
mass of muscle cuff was incorporated into the anastomosis
(group III). With a running suture line, the needle was
placed into the infundibular muscle of the autograft
Fig. 1. Age distribution of children undergoing the Ross
procedure.
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extremely close to the valve leaflets (at the “anulus”), just
as in a standard Ross procedure (Fig. 4). The running
suture thereby incorporated the entire mass of infundib-
ular muscle into the suture line, allowing this muscle mass
to compensate for the larger aortic root diameter without
stretching the anulus of the autograft. The native aortic
anulus was not plicated or tailored to accommodate the
smaller autograft valve. In eight of the nine cases, reduc-
tion ascending aortoplasty was also performed by remov-
ing a triangular wedge of the anterior aspect of the
ascending aorta (Fig. 4).
Additional procedures included left ventricular outflow
tract myectomy or membrane resection in six cases, at-
tempted aortic valve repair before resorting to the Ross
procedure in six cases, a sinus obliteration procedure18 in
15 cases, mitral valve repair in one case, and internal
thoracic artery bypass of the left anterior descending
coronary artery in one case.
Data analysis. Perioperative data were collected by
retrospective review of patient records. Follow-up was
carried out by direct contact with referring physicians and
was current and complete in all cases. Statistical analysis
was performed with SPSS software version 7.0 (SPSS Inc.,
Chicago, Ill.). Follow-up autograft valvular regurgitation
was the primary dependent variable assessed, and was
scored on a scale of 0 to 4, with 0 for none, 1 for a trace,
2 for mild, 3 for moderate, and 4 for severe. For the
purposes of analysis, autograft regurgitation was treated
as an ordinal variable (0 through 4) and also collapsed
into two separate sets of dichotomous variables, with less
than mild and mild or greater as one set of categories and
mild or less and more than mild as the other. Although the
difference between mild and less than mild regurgitation
was not considered clinically important, this distinction
was made for the purpose of dichotomous analysis be-
cause of the small number of patients with more than mild
regurgitation.
Analysis of autograft regurgitation as an ordinal vari-
able was performed with the Wilcoxon signed-rank test for
categoric independent variables (such as previous or
concurrent left ventricular outflow tract procedure, sinus
obliteration technique, and attempted valve repair) and
with general factorial analysis of variance for continuous
variables (such as age, annular mismatch, cardiopulmo-
nary bypass time, and duration of follow-up). When
autograft regurgitation was analyzed as a dichotomous
variable,2 analysis was used to compare categoric indepen-
dent variables and the unpaired t test was used to compare
the mean values of continuous variables. Time-related
analysis was performed with the Kaplan-Meier product-
limit method and the Cox proportional hazards model.
Separate time-related analyses were performed with out-
come events defined as reoperation, more than mild
autograft regurgitation, and mild or more autograft regur-
gitation. Because no significant risk factors for these
outcomes were identified, time-related analysis was not
performed with autograft regurgitation treated as an
ordinal variable. Factors analyzed for correlation with
autograft regurgitation and reoperation included age,
primary diagnosis, previous or concurrent left ventricular
outflow tract operations, sinus obliteration, attempted
aortic valve repair, and cardiopulmonary bypass or aortic
crossclamp time.
Results
Operative outcomes. No abnormal pulmonary
valve morphologic characteristics were found on
intraoperative inspection. In six cases aortic valve
repair was attempted with an unsatisfactory result
before the decision was made to proceed with the
Ross procedure at the same operation. We have
previously reported on these cases in an article that
examined factors favoring a Ross procedure rather
than aortic valve repair.19
Among 41 children there was one early death,
that of a patient with severe subaortic stenosis who
underwent the procedure 5 months after repair of
interrupted aortic arch with subaortic resection and
ventricular septal defect closure. This patient ar-
rested on the table shortly after anesthesia induc-
tion, and the heart could not be restarted. Cardio-
pulmonary bypass was instituted and the Ross
procedure was performed, but the patient could not
Table I. Indications for the Ross procedure in
children (n 5 41)
Indication
No. of
patients
Congenital aortic stenosis 29
Now with aortic stenosis and regurgitation 22
Now with aortic stenosis 2
Now with aortic regurgitation 5
Subvalvular aortic obstruction 13
Supravalvular aortic obstruction 4
Congenital aortic regurgitation 3
Rheumatic heart disease 3
Shone’s complex 2
Mechanical valve stenosis (growth-related
patient-prosthesis mismatch)
1
Numbers of patients do not total 41 because of multiple diagnoses in
individual patients.
Table II. Previous left ventricular outflow tract
interventions (n 5 41)
Procedure
No. of
patients
No. of
procedures
Surgical valvotomy or valvuloplasty 18 23
Transcatheter balloon valvuloplasty 13 17
Aortic arch repair* 8 11
Subaortic resection 4 4
Aortic valve replacement 1 1
Konno aortoventriculoplasty 1 1
No previous operations 16
No previous interventions (surgical
or catheter)
8
*Includes coarctation, interrupted arch, and recurrent arch obstruction.
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be separated from bypass. Echocardiography per-
formed before discharge showed none or trivial
autograft regurgitation in 34 of the 40 survivors and
mild regurgitation in the remaining six. There was
no difference in early postoperative regurgitation
according to preoperative annular mismatch or any
of the other variables analyzed.
Follow-up. There have been no late deaths. Pa-
tients were followed up for a median of 31 months
(range 4 to 46 months)after the Ross procedure,
with seven patients followed up for longer than 3
years, 27 for longer than 2 years, and four for less
than 1 year. During this time two patients have
undergone reoperation. A group II patient (preop-
erative annular mismatch of 3.5 mm) had recurrent
arch obstruction, with resulting progressive au-
tograft regurgitation, and required aortic arch aug-
mentation and commissural resuspension of the
autograft valve 19 months after the Ross procedure.
This patient had trace autograft regurgitation 13
months after reoperation. A group III patient (an-
nular mismatch of –3 mm) had moderate to severe
autograft regurgitation and required mechanical
aortic valve replacement. This patient had excellent
valve function 12 months after the Ross operation,
but moderate to severe autograft regurgitation de-
veloped acutely in a short period, and the patient
underwent reoperation 11 months later. There was
no evidence of neoaortic annular dilatation. Actuarial
freedom from reoperation was 97% at 1 year after the
operation and 95% at 19 months and beyond.
Among the remaining 38 children, none had
autograft stenosis develop, and neoaortic regurgita-
tion at follow-up was trivial or none in 30, mild in
seven, and moderate in one. Among the 34 patients
with no or trivial autograft regurgitation at dis-
charge from the hospital, three had progression to
mild regurgitation at follow-up and one had pro-
gression to moderate regurgitation (this was the
patient who required reoperation for recurrent arch
obstruction). One of the six patients with mild
regurgitation at discharge had moderate regurgita-
tion at follow-up. Otherwise, follow-up autograft
regurgitation was not different from that in the early
postoperative period. Accordingly, early postopera-
Fig. 2. Ross-Konno procedure, performed when the au-
tograft is larger than the native aortic anulus (AAn). The
autograft is harvested with a an extension of infundibular
muscle, which is used to patch the Konno incision in the
interventricular septum (IVS), thereby enlarging the left
ventricular outflow tract. The right ventricular outflow
tract is then reconstructed with an allograft conduit, as in
the standard Ross procedure (not shown). Ao, Aorta; PA,
pulmonary artery.
Fig. 3. Usual appearance of the harvested autograft, with
a small cuff of infundibular muscle, is shown on the left.
The autograft is taken with a wider cuff of infundibular
muscle, as depicted on the right, when the native aortic
anulus is larger than the pulmonary anulus.
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tive autograft regurgitation was significantly associ-
ated with follow-up autograft regurgitation (p ,
0.001) by x2 analysis. However, mild autograft re-
gurgitation in the early postoperative period did not
correlate with likelihood of progression to more
than mild regurgitation or with the need for reop-
eration at follow-up (p . 0.36 for both). Actuarial
freedom from more than mild autograft regurgita-
tion was 95% at 1 year after the operation and 92%
at 2 to 4 years. Freedom from mild or more au-
tograft regurgitation was 90% at 1 year and 80% at
2 years. No patient was found to have evidence of
significant autograft root dilatation, and there was
no evidence of recurrent subaortic obstruction or
septal patch aneurysm in any of the 12 patients who
underwent a Ross-Konno procedure.
The distribution of follow-up autograft regurgita-
tion according to the preoperative pulmonary-aortic
annular mismatch is depicted in Fig. 5, with group I, II,
and II patients indicated separately. As can be seen
clearly in the figure, there was no correlation between
the degree of annular mismatch and postoperative
autograft function. This was also true when regurgita-
tion was analyzed as a dichotomous variable (lowest p
value for either of these analyses was 0.57). These
results did not change when annular mismatch was
analyzed as a ratio of pulmonary-aortic annular diam-
eter difference to pulmonary annular diameter, with
regurgitation treated as either an ordinal or dichoto-
mous variable (lowest p value was 0.44). The degree of
autograft regurgitation at follow-up (according to both
time-related and time-independent analyses) did not
correlate with any of the other variables analyzed.
Discussion
The pulmonary autograft is proving to be an
effective and reliable method of aortic valve replace-
ment in children for whom adequate repair cannot
be achieved with plastic techniques. It most likely
retains growth potential, does not require anticoag-
ulation or induce an immune response, is less prone
to the complication of endocarditis than other pros-
theses, and has demonstrated excellent perfor-
mance.1, 6, 7, 9, 13 Because the early mortality rate is
generally low,1-6, 8 the major outcome of interest for
patients undergoing the Ross procedure is autograft
valve function. To date, functional results have been
encouraging, with Gerosa and coworkers6 and El-
kins and associates10 both reporting approximately
90% freedom from aortic valve reoperation at 5
years and 85% freedom at 8 years. In addition, most
series report extremely few cases of significant sys-
temic outflow gradient or autograft regurgitation
more than mild in degree.7, 8, 12, 13, 15, 17 Despite the
generally good long-term functional results, there
remains considerable room for improvement in both
outcomes and patient selection. It is thus important
at this juncture to focus on identifying discrete
morphologic and technical factors that contribute to
autograft regurgitation.
Although growth of the transplanted autograft in
Fig. 4. The autograft with a wide infundibular cuff is
sutured to the larger aortic anulus (AAn) with a running
suture technique, which can be performed to exert a
purse-string effect, allowing any residual geometric dis-
crepancy to be compensated for by gradual reduction
along the course of the entire suture line. A reduction
ascending aortoplasty is also shown, with a wedge of aortic
wall tissue removed and closed primarily. The sinus
obliteration technique, shown at bottom, can also be
added. Ao, Aorta; PA, pulmonary artery.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 115, Number 6
Reddy et al. 1 2 5 9
children has not been demonstrated definitively,
several clinical studies3, 7, 9 and experimental work11
suggest that growth potential is indeed maintained.
Both growth and function of the autograft are
probably influenced by technical factors. For exam-
ple, it has been proposed that growth potential may
be optimized by use of a root replacement tech-
nique, which we employ in all cases, rather than
freehand or inclusion cylinder approaches.3, 9 More-
over, as both physiologic and morphologic studies
show, the semilunar valve root is a complex struc-
ture, and structural integrity of the entire root is
important in valve function.20, 21 In cases of size
discrepancy between the pulmonary and aortic
anuli, the importance of implanting the autograft
without distortion of the root is obvious. Because
the aortic valve dysfunction in most children under-
going the Ross procedure is either congenital or
associated with other congenital anomalies, size
differences between the semilunar valve roots are
common. Techniques to accommodate and neutral-
ize geometric mismatch will thus be especially im-
portant in the pediatric population. The issue of
whether annular size mismatch should be consid-
ered a contraindication to the Ross procedure in
this population has not been previously addressed.
When the native pulmonary valve is larger than
the aortic valve, the left ventricular outflow tract can
be enlarged by performing an autograft aortic valve
replacement with a Konno-type ventriculoplasty.
We previously described our experience with the
Ross-Konno procedure in some of the cases in-
cluded in this series.14 Others have reported simi-
larly promising outcomes.5, 13 This approach is an
attractive alternative for young patients with aortic
valve disease and subaortic stenosis because it pro-
vides relief at both levels of obstruction. We typi-
cally use infundibular muscle for our septal patch,
because it fits naturally with the curve of the septum
and because it is native tissue and presumably allows
for growth of the patch along with the autograft. On
occasion we use synthetic material for the patch,
which is the primary technique employed in other
reports.5, 13 None of our patients have had aneu-
rysms develop at the patch site, and it remains
unclear whether one approach will prove substan-
tially better than the other.
In cases of an aortic root wider than the autograft,
our approach is to excise the autograft with a slightly
larger than usual cuff of infundibular muscle, which
increases the diameter of the autograft sufficiently to
compensate for the discrepancy in annular size. A
running suture technique is used for implanting the
autograft, which tends to have a slight purse-string
effect on the circumference of the aortic root,
further aiding in adjustment for annular size mis-
match. In addition, we often remove a wedge of
ascending aortic tissue in these patients to reduce
the diameter, and hence wall tension, of the au-
tograft–to–ascending aorta anastomosis. This prac-
tice is based on biomechanical studies that have
shown the sinotubular junction of the pulmonary
root to be significantly more distensible than that of
the aortic root or the anulus of either semilunar
valve,22 which raises the concern that the autograft–
to–ascending aorta anastomosis may be the most
vulnerable point in the reconstructed left ventricular
outflow tract with respect to the development of
autograft regurgitation. Our approach differs from
previously reported tailoring procedures, in which
the root diameter is reduced either by removing a
wedge of tissue from the aortic anulus and repairing
the defect17 or by plicating the fibrous tissue at the
Fig. 5. Distribution of pulmonary valve (PV)–aortic valve
(AV) annular diameter mismatch according to degree of
autograft regurgitation at follow-up echocardiography
(28 6 11 months). Mod, Moderate.
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base of one or both commissures of the noncoronary
aortic sinus.16 Techniques of reinforcing the over-
sized aortic anulus with pericardium or synthetic
material have proved of use in older patients, but
they cannot be applied in young children because
they are likely to impinge on autograft growth
potential. Regardless of the approach selected, full
root replacement (as opposed to freehand valve or
inclusion cylinder implantation) allows maintenance
of autograft root integrity and technically easier
adjustment for annular size.
For children with and without annular mismatch,
no significant predictors of autograft regurgitation
were found in this study. In both patients who
required reoperation, there was a mild degree of
preoperative annular mismatch, with the pulmonary
valve 3 mm larger in one patient and 3.5 mm smaller
in the other. Although geometric mismatch is almost
certainly a potential cause of autograft dysfunction,
surgical techniques described here and by others15-17
can satisfactorily neutralize this mismatch in pa-
tients of all ages. Sinus obliteration was not found to
correlate with better autograft valve function, but
we consider this technique an important component
of the Ross procedure, especially for older patients
with relatively thin-walled pulmonary arteries. Al-
though our results are limited by the relatively short
follow-up and thus may not be predictive of long-
term outcome, they are nevertheless encouraging.
The Ross procedure is an important advance in
the treatment of aortic valve disease in neonates and
infants with congenital aortic stenosis or regurgita-
tion and in other young patients with aortic valve
dysfunction. Even when there is significant geomet-
ric mismatch between the pulmonary and aortic anuli,
techniques can be used to allow implantation with
maintenance of autograft competence. Geometric
mismatch of the semilunar valve anuli is not a contra-
indication for the Ross procedure in children.
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Discussion
Dr. Jan M. Quaegebeur (New York, N.Y.). I share your
enthusiasm about the Ross operation in terms of its
effectiveness in the treatment of children with severe left
ventricular outflow tract obstruction. I believe that its
performance easily surpasses that of any alternative. The
results, as you have shown and also in our experience, are
excellent both in terms of reduction of gradients and in
terms of survival. Despite the complexity of the operation,
it yields excellent results when done in institutions who are
prepared to undertake such an operation.
In terms of the annular mismatch problems in those
patients, most patients in our experience, as in yours I
believe, have aortic stenosis. I agree that the aortic anulus
is usually much smaller, and the pulmonary anulus can be
as much as 300% larger than the aortic anulus. We have
been using the procedure you described, the “glorified
Ross procedure” as I call it, for many years with the same
excellent results.
Regarding the mismatch in the other direction, I am a
bit puzzled, because we do not seem to find that type of
difference, with the pulmonary anulus smaller than the
aortic anulus. In analyzing our data, we have been more
and more concerned about the long-term performance of
the neoaortic root in terms of incompetence and dilata-
tion. My first question is therefore whether you find an
influence of age among patients who have smaller pulmo-
nary anuli than aortic anuli? Does this happen in older
patients rather than younger patients?
Second, if you use a larger amount of infundibulum
underneath the autograft, you have a floppy area under-
neath the aortic anulus. I have always stressed the fact that
the proximal suture line should almost be inserted inside
the left ventricular outflow tract to support it. Does that
influence the stability of the autograft?
Third, in the intriguing case in which severe incompe-
tence developed after initial valve competence, have you
determined whether this patient had rheumatic disease to
start with? Some patients with rheumatic disease would
have autograft destruction earlier than seen in other
patients. It may be that this is a group of patients who
should still undergo another form of treatment.
Dr. James H. Oury (Missoula, Mont.). I compliment you
and your coauthors on an excellent series and to support
your conclusions. In the International Ross Registry Data,
a database now available through the Internet and housed
at our hospital in Missoula, Montana, we have more than
2500 cases listed. In looking at the incidence of postoper-
ative aortic insufficiency, if you take what I would call the
worst-case scenario—that is, patients who have significant
degrees of preoperative aortic insufficiency—and who
have all had echocardiographic follow-up, we have data
available for 1656 patients. The incidence of moderate to
severe aortic insufficiency is 4% in this group. I stress that
these are all patients who have had postoperative echo-
cardiographic evaluation. Keep in mind that in a normally
functioning mechanical bileaflet valve, the regurgitant
fraction is in the 6% neighborhood. I think this puts the
incidence of postoperative aortic insufficiency with the
Ross procedure into some perspective.
We have analyzed a subgroup of athletes who have been
exposed to severe exercise. All these athletes have under-
gone the Ross procedure. In this series the incidence of
aortic insufficiency did not change with severe exercise.
These athletes went to between 6 and 8 in the modified
Bruce protocol, so they were exercising maximally. My
conclusion from this is that significant postoperative aortic
insufficiency is not inherent in the Ross procedure; how-
ever, I believe that it is due to technical factors in the
operation. In addition, these athletes had normal (physi-
ologic) gradients at maximal exercise.
I have two questions. First, at what age would you
consider some form of external annular support? I note
that the age range of your patients was 4 to 18 years.
Second, at what annular ratio or aortic-to-pulmonary
annular mismatch would you consider altering your tech-
nique, either interrupting the proximal suture line associ-
ated with an external form of annular support, doing an
annuloplasty, or possibly even abandoning the procedure?
Dr. Thomas L. Spray (Philadelphia, Pa.). You men-
tioned that you decrease the size of the aorta distal to the
autograft implantation when there is that sort of size
discrepancy. In most of these cases, however, the size
discrepancy is in the opposite direction. In our own
experience of about 48 such pediatric Ross operations, a
significant number of these children have had an ex-
tremely small ascending aorta but a good-sized proximal
autograft. Would you comment on the techniques you use
to make up this size discrepancy? At least in our experi-
ence, distal obstruction has been associated with early
insufficiency of the autograft, fortunately not severe
enough to require reintervention.
Would you also comment on the magnitude of pulmo-
nary valve abnormality that you would consider acceptable
for use in a Ross operation? Many of these patients have
undergone previous operations, including ventricular sep-
tal defect closure, for example, and there may be scarring
underneath the pulmonary valve leaflets. Again, in our
experience, the only patients who have needed reopera-
tion had an abnormal pulmonary valve at the time of the
Ross operation.
Dr. Vaughn A. Starnes (Los Angeles, Calif.). I just
wanted to comment on one subgroup of patients with the
case presentation that you had, the early infants, younger
than 3 months. Would you comment on the presence or
absence of endocardial fibroelastosis in that group of
patients and also on the impact it possibly has on the other
valve, the mitral valve? We have about 12 patients in that
group, and we have unmasked severe mitral pathology in
three cases. It is as though this is a whole left ventricular
outflow tract syndrome.
Dr. Hanley. I appreciate all the interest. Dr. Quaege-
beur’s first question addressed the influence of age on
valve mismatch. I agree completely with his observations
that in the extremely young infants, the group with critical
aortic stenosis, it is essentially unheard of for the pulmo-
nary valve to be smaller than the aortic valve. The aortic
valve is always smaller than the pulmonary valve.
We did have a number of patients in the series in whom
the pulmonary valve was smaller, but all were in the older
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age range and had primary aortic insufficiency as their
pathology. I do not know that there is any real difference
between our data and Dr. Quaegebeur’s observations. To
reemphasize, we saw no neonates or young infants in
whom the pulmonary valve was smaller than the aortic
valve.
I would also like to make the point that the pulmonary
valve does not really vary much except in the patients Dr.
Spray mentioned, in whom there may have been a previ-
ous large ventricular septal defect. This is a very small
subpopulation of patients undergoing the Ross operation,
although they do exist. Generally speaking, we are looking
at a relatively normal pulmonary valve with the aortic
valve either small, normal, or very, very large. This is what
determines the mismatch in this ratio.
Dr. Quaegebeur’s second question is an extremely
pertinent question related to our technique, in those cases
in which the aortic valve is larger, of using the slightly
bulked up pulmonary infundibulum to bridge that mis-
match. I agree completely with all his concerns. It is
important to bring the suture line right up to the nadir of
the cusps of the three leaflets of the autograft. To leave a
large section of infundibular muscle would invite disaster.
I did not want to focus the presentation on the specific
details of the technique; however, the purpose of that
extra tissue is not to bring the infundibulum up higher off
the new aortic root but rather to provide some bulk to
“stuff” into the larger aortic anulus. The sutures still do
come all the way up to the autograft cusps, but we take
wide running sutures to bulk up all this infundibular
muscle. This muscle takes up space in the aortic root. The
suture line, to reemphasize, is not further away from the
anulus than in the normal technique.
The patient with normal function a year after the
operation who then had sudden development of severe
aortic insufficiency was evaluated extremely carefully.
There was no evidence of rheumatic disease and no
clinical event of endocarditis that we could determine.
When we took the valve out, the valve did not appear to
be destroyed. There is no good explanation for the
development of aortic insufficiency in this case.
Dr. Oury asks at what age we would think of providing
external annular support. I do not know that I have given
that question much thought. According to Robert Gross’s
theories about aortic coarctation, when a child reaches
about 8 to 10 years old, the distal aorta is about 50% of
normal adult size. If it never grows further, there will
probably never be any hemodynamic stenosis at that
point. On the basis of this, I would probably not even
consider it in anyone younger than 8 years, and I do not
think it would be too much of a growth-inhibiting factor in
anybody older than 12 years.
Another question asks at what ratio limit of aortic valve
and pulmonary valve we would abandon the procedure.
That is a difficult question. With the Ross-Konno tech-
nique for the tiny aortas, we have shown, as Dr. Quaege-
beur mentioned, a 300% difference. I do not think that the
ratio gets much larger than that. If the ratio is in the other
direction, I do not know that I can come up with an
absolute number. We have not yet encountered a case in
which we believed that we could not deal with the
mismatch.
With regard to Dr. Spray’s comments about the distal
arch augmentation, I agree completely. In most young
patients one is dealing with a hypoplastic aorta and it is in
fact necessary to augment the distal aorta. We have done
that in quite a number of these cases. In a couple of
patients with hypoplastic arches, a Norwood type of
extension all the way around the hypoplastic arch was
performed. In some of our Ross-Konno cases we have
performed this procedure. Whenever necessary, we make
an anterior incision and place a triangular patch for
isolated ascending aortic hypoplasia. Usually it is a piece
of the homograft that we are using for the right ventricular
outflow tract reconstruction.
In terms of pulmonary valve abnormalities and size,
again, if the abnormality is only a size difference, we have
not yet encountered a valve that has made us think that we
should not do this procedure. In terms of abnormalities,
we have had a couple of patients with bicuspid pulmonary
valves and have not done the Ross procedure under those
circumstances. We usually accept trivial central physio-
logic pulmonary insufficiency before the operation, but we
have not encountered any other pulmonary valve abnor-
malities per se.
Dr. Spray. We have actually seen one valve that had a
separation of the commissural attachments of the cusps by
about 5 mm with an otherwise normal valve. It was
extremely tempting to try to bring that commissure back
together again, so we did that, implanting it as an au-
tograft. It worked fine for about 3 days and then tore out
and had to be replaced. That is the instance in which it
failed, and I have been reluctant to consider using any
abnormal pulmonary valves since that experience.
Dr. Hanley. I have not had that exact experience, but in
general I think it is prudent to be extremely rigid in
examining the pulmonary valve and, if any abnormality of
concern is present, to fight the tendency to move ahead
with the operation as planned. I would agree to abort the
Ross procedure if there were significant abnormalities.
To briefly address Dr. Starnes’ comment about endo-
cardial fibroelastosis, many of these patients do have it,
usually the neonates and small infants. I am sorry that I
did not bring a slide of a specimen that looks like the shell
of a hard-boiled egg, in which we resected a 1 to 2 mm
thick endocardial fibroelastosis all the way down to the
apex, sparing the papillary muscles. That is an extraordi-
nary example of a relatively common problem. When we
do the Konno incision, which is quite common in these
small infants, we resect an extensive amount of the
endocardial fibroelastosis. We agree that mitral valve
dysfunction, when one sees these sort of mummified
papillary muscles, is of great concern; I do not think that
there is anything you can do with the papillary muscles.
When one resects the endocardial fibroelastosis, I think
that it is important to stay away from the base of the
papillary muscle even if you go beyond it down into the
apex, which we have done on a number of occasions. This
is a common scenario.
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